India's bioeconomy valued at $150 bn, innovation holds key to global leadership: BIRAC MD

India's biotechnology sector, valued at USD 150 billion, is expanding, yet innovation and product development potential remain untapped. BIRAC supports startup growth and R&D investment to elevate India's bioeconomy, though increased private-sector investment and streamlined regulatory processes are essential for global leadership in biotech.